NKTX

Nkarta Inc (NKTX)

US
$ 00%

Price Chart

Key Statistics

Market Cap
$ 165.49M
P/E Ratio
0.00
Revenue (TTM)
$ 385
Volume
0
52W High
$ 6.63
52W Low
$ 1.31
Dividend Yield
0.00%
Beta
0.73

Technicals

50-Day MA
1.9355
200-Day MA
2.1238
52 Week High
6.6279
52 Week Low
1.31

About NKTX

Nkarta, Inc., a clinical-stage biopharmaceutical company, develops and commercializes natural killer cell therapies for cancer and autoimmune disease treatment.

Employees
157
Headquarters
South San Francisco, CA
CEO
Mr. Paul J. Hastings

Latest News

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg

Top Losers

Symbol/Name
LTP
% Chg